National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 13724 [2024-03669]
Download as PDF
<![CDATA[
13724
Federal Register / Vol. 89, No. 37 / Friday, February 23, 2024 / Notices
living organ donors in their decision to
pursue living donation.
Likely Respondents: Potential and
actual living donors, transplant
programs, medical and scientific
organizations, and public organizations,
including patient advocacy groups.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total
burden hours
Potential Living Donor Registration Form ............................
Potential Living Donor Follow-up Form ...............................
Reasons Did Not Donate Form (Liver or Kidney) ...............
a 16
c 112
c 1,792
e 0.27
b 754
d 754
f 0.50
a 16
1
c 106
c 1,696
g 0.23
484
377
390
Total ..............................................................................
a 786
........................
4,242
........................
1,251
a Number
of respondents is based on the current number of transplant programs and is likely to increase as additional programs decide to par-
ticipate.
b Number of living donor candidates that submitted follow-up forms in 2019.
c Derived from the number of forms submitted by transplant programs in 2019.
d Total number of Living Donor Collective follow-up forms submitted by living donor candidates in 2019.
e Based on a 2019 survey of transplant programs submitting data to the Living Donor Collective.
f Based on internal testing and user feedback.
g Based on discussion and interviews with staff at participating transplant programs in 2019–2020.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–03759 Filed 2–22–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Allergy, Immunology, and
Transplantation Research Committee (AITC)
Special Emphasis Panel.
Date: March 18, 2024.
Time: 10:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
17:19 Feb 22, 2024
Jkt 262001
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G31B, Rockville, MD
20852, (240) 669–5060, james.snyder@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–03669 Filed 2–22–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Center for Scientific
Review Advisory Council.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
This will be held in-person and will
be open to the public as indicated
below. Individuals who plan to attend
and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
register at: https://public.csr.nih.gov/
AboutCSR/Organization/CSRAdvisory
Council/Registration.
The meeting can be viewed remotely
via the NIH Videocasting website:
https://videocast.nih.gov/watch=54186.
Name of Committee: Center for Scientific
Review Advisory Council.
Date: March 25, 2024.
Time: 9:30 a.m. to 3:30 p.m.
Agenda: Provide advice to the Director,
Center for Scientific Review (CSR), on
matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Conference Room 160–A, Bethesda, MD
20892.
Contact Person: Bruce Reed, Ph.D., Deputy
Director, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 594–9159,
reedbr@mail.nih.gov.
Any interested person may file written
comments with the committee by
forwarding the statement to the Contact
Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person. In
the interest of security, NIH has
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 89, Number 37 (Friday, February 23, 2024)]
[Notices]
[Page 13724]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03669]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Allergy, Immunology, and
Transplantation Research Committee (AITC) Special Emphasis Panel.
Date: March 18, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852 (Video Assisted Meeting).
Contact Person: James T. Snyder, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852, (240) 669-5060, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03669 Filed 2-22-24; 8:45 am]
BILLING CODE 4140-01-P
